Skip to content
Results research

Concall Intelligence

Follow the Sept 2026 quarter results season by comparing what companies reported with what management said next. Search official call evidence, measurable guidance, changing outlook, operating risks, and prior commitments without treating commentary as a trading recommendation.

Open reported results
Matching calls
101
After selected filters
Transcript verified
37
Official transcript summaries on this page
Preliminary briefs
13
Presentation evidence, clearly labelled
Processing
0
Transcript filed or call source found
Tracked companies
0
Watchlist or portfolio matches

Management evidence

Generated 22 Oct, 10:34 pm IST · click a summary to inspect source-linked evidence for this results quarter.

Clear filters
CompanyCall and sourcesReported resultManagement outlookEvidence-led conclusionReview
CREDITACC
CREDITACCESS GRAMEEN LIMITED
Financial Services · Small
Sept 2026
22 Oct 2026
Preliminary brief
Excellent
85/100
Optimistic outlook
No comparable prior call
Guidance raised

CreditAccess Grameen Limited reported strong financial and operating performance for Q2 FY27, driven by robust AUM growth, improving asset quality back to pre-crisis levels, and higher profitability resulting in the highest-ever quarterly PAT crossing INR 500 Cr. Management revised FY27 performance guidance upwards across key return and margin metrics, supported by disciplined operating costs and strong capital positions.

Evidence summary ready
AURUM
Aurum PropTech Limited
IT · Small
Sep 2026
22 Oct 2026
Preliminary brief
Average
32/100
Optimistic outlook
No comparable prior call
No measurable guidance

Aurum PropTech reported strong consolidated revenue growth of 57% YoY to Rs 137 Cr in Q2 FY27 along with an improvement in profitability margins, backed by aggressive AI transformation across platforms and upcoming integration of Housing.com.

Evidence summary ready
ROSSARI
Rossari Biotech Limited
Pharma · Small
Sep 2026
22 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Cautious outlook
No comparable prior call
No measurable guidance

Rossari Biotech delivered its highest-ever quarterly revenue and EBITDA in Q2 FY27, supported by broad-based divisional growth and an improving export share. However, management remains cautious due to raw material volatility, Middle East geopolitical tensions impacting freight and logistics, and constrained ethylene oxide availability.

Evidence summary ready
FEDFINA
Fedbank Financial Services Limited
Financial Services · Micro
Sept 2026
22 Oct 2026
Transcript verified
Excellent
85/100
Optimistic outlook
No comparable prior call
Guidance maintained

Fedbank Financial Services Limited delivered a strong Q2 FY27 with total disbursements up 28% YoY to INR6,676 crores and AUM up 37% YoY to INR22,035 crores. PAT reached INR130.8 crores (up 63% YoY), driven by an expanded ROA of 2.8% and ROE of 17%. Management highlighted that heightened competitive intensity in the gold loan market was managed effectively without compromising yields significantly, while mortgage collections and credit costs improved.

Evidence summary ready
IIFL
IIFL Finance Limited
Financial Services · Small
Sep 2026
22 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
Guidance maintained

IIFL Finance reported robust performance for Q2 FY27, with consolidated AUM reaching INR1,24,268 crores (up 38% YoY and 8% QoQ) and consolidated PAT crossing INR805 crores, up 13% QoQ and 93% YoY. The return on equity surpassed the 20% target at 20.1%, supported by steady asset quality (consolidated gross NPA improved by 7 bps QoQ to 1.48%), increased liquidity of INR13,805 crores, and stable capital adequacy of 23.5%. However, management faces challenges including capital-ra

Evidence summary ready
THELEELA
Leela Palaces Hotels & Resorts Limited
Consumer · Large
Sep 2026
22 Oct 2026
Transcript verified
Excellent
85/100
Optimistic outlook
No comparable prior call
Guidance maintained

Leela Palaces Hotels & Resorts delivered exceptional performance in Q2 FY27 with 33% operating revenue growth and 36% EBITDA growth, supported by robust luxury demand, pricing power, and strong performance during marquee events like the BRICS summit in New Delhi.

Evidence summary ready
JINDALSAW
Jindal Saw Limited
Industrials · Large
Sept 2026
22 Oct 2026
Transcript verified
Bad
0/100
Optimistic outlook
No comparable prior call
Guidance maintained

Jindal Saw delivered higher year-on-year revenues for Q2 FY27 but faced severe operational margin compression due to geopolitical tensions in West Asia delaying shipments, higher international/domestic logistics costs, soaring coking coal prices, and softness in the domestic water infrastructure segment.

Evidence summary ready
IRFC
Indian Railway Finance Corporation Limited
Financial Services · Large
Sep 2026
22 Oct 2026
Transcript verified
Average
50/100
Optimistic outlook
No comparable prior call
Guidance maintained

IRFC reported a robust performance for Q2 FY26-27, driven by successful business diversification and double-digit PAT growth across five of the last six quarters. Management remains confident in achieving its near-term and long-term AUM and profitability milestones while maintaining a low weighted average cost of capital.

Evidence summary ready
UJJIVANSFB
Ujjivan Small Finance Bank Limited
Financial Services · Micro
Sep 2026
22 Oct 2026
Transcript verified
Excellent
85/100
Optimistic outlook
No comparable prior call
Guidance maintained

Ujjivan Small Finance Bank announced the early retirement of its MD & CEO due to health reasons and appointed Ms. Carol Furtado as Interim MD & CEO. Management reassured stakeholders of continuity in strategy, strong governance, and commitment to FY27 guidance, emphasizing that growth plans and capital adequacy remain unaffected by the leadership transition or potential delays in capital raising. The search for a permanent MD & CEO has been expedited.

Evidence summary ready
AYE
Aye Finance Limited
Financial Services · Small
Sept 2026
22 Oct 2026
Preliminary brief
Excellent
85/100
Optimistic outlook
No comparable prior call
Guidance maintained

Aye Finance Limited delivered a strong operational and financial performance in Q2 FY27, driven by robust AUM growth, improving asset quality, and record quarterly profitability supported by enhanced operational efficiency and lower credit costs.

Evidence summary ready
ELECON
Elecon Engineering Company Limited
Industrials · Large
Sept 2026
22 Oct 2026
Transcript verified
Good
55/100
Optimistic outlook
No comparable prior call
Guidance maintained

Elecon delivered resilient H1 FY27 performance with 11% consolidated revenue growth and a stable EBITDA margin of 22.2%, supported by robust international momentum in gears and recovering project clearances in the MHE division despite near-term domestic softness and raw material volatility.

Evidence summary ready
SRF
SRF Limited
Chemicals · Mid
Sept 2026
22 Oct 2026
Preliminary brief
Average
52/100
Optimistic outlook
No comparable prior call
No measurable guidance

SRF Limited reported a consolidated revenue of 4,904.2 Cr and a PAT of 509.1 Cr for Q2 FY27, backed by robust growth in the Chemicals and Performance Films businesses, while navigating elevated input, freight, and fuel costs.

Evidence summary ready
JIOFIN
Jio Financial Services Limited
Financial Services · Large
Sep 2026
22 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
No measurable guidance

Jio Financial Services reported strong operational scale-up across its core verticals during Q2 FY27, backed by 154% YoY growth in Jio Credit AUM and significant digital user engagement, though consolidated reported PAT declined due to shifting dividend timing effects compared to the previous year.

Evidence summary ready
LTM
LTM Limited
IT · Large
Sept 2026
22 Oct 2026
Transcript verified
Bad
0/100
Optimistic outlook
No comparable prior call
Guidance maintained

LTM Limited reported steady Q2 FY2027 performance with 1.1% QoQ constant currency revenue growth and stable EBIT margins of 15.6%, while pivoting strongly toward AI-centric offerings and advancing strategic M&A execution.

Evidence summary ready
TARIL
Transformers And Rectifiers (India) Limited
Industrials · Large
Sept 2026
21 Oct 2026
Transcript verified
Excellent
100/100
Optimistic outlook
No comparable prior call
Guidance maintained

Transformers and Rectifiers (India) Limited delivered robust performance in Q2 FY27 with revenue up 60.8% YoY and PAT jumping 120.0% YoY, supported by improved capacity utilization and operating leverage. Unexecuted order book remains strong at INR7,237 crore, providing solid multi-year visibility despite lingering working capital pressures and elevated inventory levels.

Evidence summary ready
IGIL
International Gemmological Institute (India) Limited
Services · Large
Sept 2026
21 Oct 2026
Preliminary brief
Excellent
100/100
Optimistic outlook
No comparable prior call
No measurable guidance

International Gemmological Institute (India) Limited reported robust financial performance for Q2 FY27, with consolidated revenue up 31% YoY to INR 3,980 Mn and PAT up 43% YoY to INR 1,858 Mn, driven by strong growth in certification volumes and increased mix of lab-grown diamonds (LGD).

Evidence summary ready
360ONE
360 ONE WAM LIMITED
Financial Services · Mid
Sept 2026
21 Oct 2026
Transcript verified
Bad
0/100
Cautious outlook
No comparable prior call
No measurable guidance

Quarterly results showed modest revenue growth and a decline in profit, while management highlighted strong AUM growth, improved ARR retention, and long‑term profitability targets, but flagged margin pressure from higher costs and reliance on UBS flow execution.

Evidence summary ready
WAAREERTL
Waaree Renewable Technologies Limited
Industrials · Micro
Sept 2026
21 Oct 2026
Preliminary brief
Bad
2/100
Optimistic outlook
No comparable prior call
No measurable guidance

Waaree Renewable Technologies Limited reported strong top-line growth with Q2 FY27 revenue up 36.5% YoY to Rs 1,057.84 Cr, alongside a healthy unexecuted order book exceeding Rs 5,500 Cr. However, PAT contracted by 29.98% YoY to Rs 81.48 Cr due to higher input costs, employee expenses, and financing costs, leading to margin compression.

Evidence summary ready
CCL
CCL Products (India) Limited
FMCG · Large
Sept 2026
21 Oct 2026
Transcript verified
Average
47/100
Optimistic outlook
No comparable prior call
Guidance maintained

CCL delivered strong Q2 results with double‑digit volume growth and profit expansion, and management reaffirmed its FY27 guidance of ~15% volume and EBITDA growth, while noting coffee price volatility and capacity considerations.

Evidence summary ready
EMMVEE
Emmvee Photovoltaic Power Limited
Industrials · Large
Sep 2026
21 Oct 2026
Transcript verified
Good
67/100
Optimistic outlook
No comparable prior call
Guidance maintained

Emmvee delivered strong Q2 FY27 results with double‑digit revenue and profit growth, maintained high margins, and indicated that its expansion projects are on schedule, but future finance costs will rise post‑commissioning.

Evidence summary ready
SHOPERSTOP
Shoppers Stop Limited
Consumer · Small
Sep 2026
21 Oct 2026
Transcript verified
Bad
22/100
Optimistic outlook
No comparable prior call
Guidance raised

Shoppers Stop delivered modest top‑line growth and a turnaround to profitability, driven by strong festive demand, premiumisation initiatives and new store openings, while highlighting ongoing work on inventory and working‑capital optimisation.

Evidence summary ready
DBCORP
D.B.Corp Limited
Media · Small
Sept 2026
21 Oct 2026
Transcript verified
Bad
0/100
Optimistic outlook
No comparable prior call
Guidance maintained

D.B. Corp reported a decline in Q2 FY27 revenue and PAT due to the festive season (Navaratra) shifting into Q3 and temporary headwinds such as panchayat election codes of conduct, though underlying advertising and EBITDA registered positive single-digit growth on a like-to-like basis.

Evidence summary ready
E2E
E2E Networks Limited
IT · Small
Sept 2026
21 Oct 2026
Transcript verified
Good
55/100
Optimistic outlook
No comparable prior call
No measurable guidance

E2E Networks delivered robust financial performance in Q2 FY27 with triple-digit YoY revenue growth and margin expansion, supported by Blackwell GPU deployment and improved utilization. Management maintains a disciplined approach to capex and avoids speculative guidance.

Evidence summary ready
ICICIPRULI
ICICI Prudential Life Insurance Company Limited
Financial Services · Large
Sep 2026
21 Oct 2026
Transcript verified
Good
65/100
Optimistic outlook
No comparable prior call
No measurable guidance

ICICI Life delivered solid revenue and profit growth despite macro volatility, with strong VNB expansion and margin stability, while emphasizing continued investment in agency distribution and upcoming regulatory reforms.

Evidence summary ready
SGFIN
SG Finserve Limited
Financial Services · Small
Sep 2026
21 Oct 2026
Transcript verified
Excellent
80/100
Cautious outlook
No comparable prior call
New guidance

SG Finserve delivered strong Q2 FY27 results with record PAT and loan book growth, but management plans to increase leverage to 4x and targets 30‑35% AUM growth YoY, introducing execution and capital‑raising considerations.

Evidence summary ready
ANGELONE
Angel One Limited
Financial Services · Small
Sept 2026
21 Oct 2026
Transcript verified
Excellent
90/100
Optimistic outlook
No comparable prior call
Guidance maintained

Angel One delivered resilient Q2 FY27 results with consolidated revenue of 14.3 billion rupees and PAT of 3.35 billion rupees despite subdued capital market volumes. Operating margins expanded significantly year-over-year, supported by operating leverage and a diversified revenue mix.

Evidence summary ready
HDFCAMC
HDFC Asset Management Company Limited
Financial Services · Large
Sept 2026
21 Oct 2026
Transcript verified
Good
55/100
Optimistic outlook
No comparable prior call
No measurable guidance

HDFC Asset Management delivered solid revenue growth and maintained high profitability, while highlighting continued expansion of SIP inflows, alternative platform launches, and disciplined cost management; however, guidance on future revenue mix and margins remains limited.

Evidence summary ready
TIPSMUSIC
Tips Music Limited
Media · Micro
Sept 2026
21 Oct 2026
Transcript verified
Good
62/100
Optimistic outlook
No comparable prior call
Guidance raised

Tips Music delivered strong top‑line and profit growth in Q2 FY27, driven by new releases and catalog performance across digital and non‑digital platforms. Management upgraded FY27 growth guidance but highlighted a front‑loaded content spend, ongoing YouTube Shorts negotiations and a smaller‑film focus for H2.

Evidence summary ready
HDBFS
HDB Financial Services Limited
Financial Services · Large
Sept 2026
20 Oct 2026
Transcript verified
Good
55/100
Optimistic outlook
No comparable prior call
No measurable guidance

HDB Financial Services delivered strong top‑line and profit growth in Q2 FY27, driven by robust disbursements across enterprise and consumer segments, improved asset quality and margins, and continued capital strength. Management is optimistic about H2, citing festive demand and capacity to scale, but flags monsoon‑related inflation, seasonal asset‑quality pressures and regulatory fee uncertainties as risks.

Evidence summary ready
PIRAMALFIN
Piramal Finance Limited
Financial Services · Small
Sep 2026
19 Oct 2026
Preliminary brief
Excellent
77/100
Optimistic outlook
No comparable prior call
Guidance maintained

Piramal Finance Limited reported strong financial results for Q1 FY27, driven by robust growth in retail lending and a granular Wholesale 2.0 portfolio, while successfully continuing the rundown of legacy wholesale assets. The company maintains solid capitalization, high liquidity coverage, and a steadily improving operating leverage.

Evidence summary ready
IXIGO
Le Travenues Technology Limited
Consumer · Micro
Sep 2026
19 Oct 2026
Preliminary brief
Average
35/100
Optimistic outlook
No comparable prior call
No measurable guidance

Le Travenues Technology Limited (IXIGO) reported resilient Q2 FY27 performance with GTV up 22% YoY and revenue from operations up 13% YoY to Rs 321 Crores, supported by strong growth in Flight and Bus segments and the new Hotel line. PAT reached an all-time high aided by a partial stake sale in Freshbus, while management continues to invest in hotels and AI capabilities.

Evidence summary ready
ULTRACEMCO
UltraTech Cement Limited
Materials · Large
Sept 2026
19 Oct 2026
Preliminary brief
Average
52/100
Optimistic outlook
No comparable prior call
No measurable guidance

UltraTech Cement reported solid year-on-year volume and earnings growth for Q2 FY27 driven by strong structural macro demand, although fuel and raw material cost inflation impacted sequential margins.

Evidence summary ready
SEJALLTD
Sejal Glass Limited
Industrials · Small
Sep 2026
19 Oct 2026
Preliminary brief
Excellent
100/100
Optimistic outlook
No comparable prior call
Guidance maintained

Sejal Glass reported strong year-on-year revenue and profit growth for Q2 FY27, driven by higher capacity utilisation, integration of acquired Glasstech plants, and robust performance from its UAE subsidiary. Management remains optimistic about achieving 25% to 40% revenue growth in FY27, supported by scaling operations and new specialty product launches.

Evidence summary ready
UNIONBANK
Union Bank of India
Financial Services · Large
Sept 2026
19 Oct 2026
Preliminary brief
Good
70/100
Optimistic outlook
No comparable prior call
No measurable guidance

Union Bank of India delivered solid financial performance for Q2 FY2027 with strong growth in Net Interest Income, improved asset quality metrics including lower GNPA and NNPA ratios, and robust capital adequacy, alongside ongoing investments in digital initiatives and centralized surveillance systems.

Evidence summary ready
HERITGFOOD
Heritage Foods Limited
FMCG · Micro
Sept 2026
19 Oct 2026
Transcript verified
Bad
0/100
Cautious outlook
No comparable prior call
No measurable guidance

Heritage Foods posted solid top-line growth but margin pressure from higher milk procurement costs led to a 39.5% YoY decline in PAT, while EBITDA margin improved sequentially.

Evidence summary ready
POLYCAB
Polycab India Limited
Industrials · Mid
Sept 2026
19 Oct 2026
Transcript verified
Good
72/100
Neutral outlook
No comparable prior call
Guidance maintained

Polycab delivered record revenue and profit growth in Q2 FY27, driven by strong demand across wires & cables and FMEG segments, while management reiterated an unchanged outlook despite macro‑headwinds and noted exposure to commodity and logistics risks.

Evidence summary ready
PSB
Punjab & Sind Bank
Financial Services · Small
Sept 2026
19 Oct 2026
Preliminary brief
Excellent
75/100
Optimistic outlook
No comparable prior call
No measurable guidance

Punjab & Sind Bank reported steady financial growth for the quarter ended June 30, 2026, supported by an expanding RAM portfolio, improved asset quality metrics, and higher profitability ratios, although the source document is an investor presentation with earnings transcripts pending.

Evidence summary ready
YESBANK
Yes Bank Limited
Financial Services · Mid
Sep 2026
19 Oct 2026
Preliminary brief
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
No measurable guidance

Yes Bank reported a Q2FY27 net profit of INR 1,080 crores, up 65% year-on-year, driven by healthy core operating income and steady asset quality, though the Supreme Court judgment on AT-1 bonds remains unrecognised pending assessment.

Evidence summary ready
TATAELXSI
Tata Elxsi Limited
IT · Mid
Sept 2026
19 Oct 2026
Transcript verified
Average
45/100
Optimistic outlook
No comparable prior call
No measurable guidance

Tata Elxsi reported Q2 FY27 operating revenue of INR 1055.7 crores (up 2.3% QoQ in constant currency) and an EBITDA margin of 21.9%, absorbing annual wage hikes through operational leverage and realization of one-offs. While US and India markets performed well, Europe remains soft and sluggish, particularly in automotive. Management expects an upward margin trajectory and better second-half performance compared to the first half.

Evidence summary ready
ICICIGI
ICICI Lombard General Insurance Company Limited
Financial Services · Mid
Sept 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
No measurable guidance

ICICI Lombard General Insurance Company Limited reported robust H1 FY2027 performance, outpacing industry growth in segments like Retail Health and Commercial lines while maintaining strict underwriting discipline, though overall PBT and PAT dipped slightly and industry-wide Motor combined ratios remained heavily stressed.

Evidence summary ready
TATATECH
Tata Technologies Limited
IT · Small
Sep 2026
19 Oct 2026
Transcript verified
Average
32/100
Optimistic outlook
No comparable prior call
No measurable guidance

Tata Technologies delivered solid revenue growth and maintained operating margin despite salary headwinds, but sequential PAT declined and technology solutions revenue fell due to accounting changes.

Evidence summary ready
KARURVYSYA
Karur Vysya Bank Limited
Financial Services · Small
Sep 2026
19 Oct 2026
Transcript verified
Excellent
75/100
Optimistic outlook
No comparable prior call
Guidance maintained

Karur Vysya Bank delivered strong revenue and profit growth in Q2 FY26-27, with business expansion and robust CASA inflows, while maintaining NIM above guidance; management signals cautious but optimistic outlook for FY26-27 growth of 18-20% and highlights competitive pressure on margins.

Evidence summary ready
IOLCP
IOL Chemicals and Pharmaceuticals Limited
Industrials · Small
Sep 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
Guidance maintained

IOL Chemicals and Pharmaceuticals Limited reported its business update call focusing on three strategic growth initiatives totalling approximately INR500 crores, including Ibuprofen capacity expansion, entry into the CDMO formulations segment, and a specialty chemical tolling arrangement. Management highlighted disciplined internal accrual funding and long-term customer relationships, while noting that input prices have stabilized and some product prices have softened from pe

Evidence summary ready
TEMPSENS
Tempsens Instruments (India) Limited
Industrials · Micro
Sep 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
Guidance maintained

Tempsens Instruments (India) Limited reported a strong Q1 FY27 with revenue growing 33% YoY to INR118 crores and export revenues rising 78.3%, while EBITDA margins moderated by 330 bps to 22% due to employee cost investments for future growth and timing of execution.

Evidence summary ready
METROPOLIS
Metropolis Healthcare Limited
Pharma · Micro
Sep 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
Guidance maintained

Metropolis Healthcare reported robust strategic positioning during its Investor and Analyst Meet, highlighting strong volume-led growth across B2C and B2B channels, expansion in tier-2/tier-3 towns, and margin expansion levers driven by specialty testing, genomics, and network productivity.

Evidence summary ready
EUROPRATIK
Euro Pratik Sales Limited
Industrials · Small
Sep 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
Guidance maintained

Euro Pratik Sales Limited announced the acquisition of a 56% stake in Fabwood Solutions LLP for up to INR42.7 crore to expand into timber and value-added wood products, while management guided for a 35% to 40% top-line growth rate for FY27.

Evidence summary ready
POLICYBZR
PB Fintech Limited
Financial Services · Mid
Sep 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Cautious outlook
No comparable prior call
No measurable guidance

PB Fintech held an analyst and investor call addressing the draft regulatory proposals by the insurance regulator concerning commissions and distribution economics. Management stated that while life insurance NPV remains largely unaffected, general insurance (particularly retail health) faces a serious top-line compression of one-third to 40%. The company plans to absorb details, evaluate cost rationalization levers, and explore manufacturing and service monetization options.

Evidence summary ready
NOVARTIND
Novartis India Limited
Pharma · Small
Sep 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
No measurable guidance

Novartis India Limited is undergoing a complete commercial reset following its acquisition by ChrysCapital. The management aims to transition the company from a flattish revenue trajectory to a high-growth platform by building an internal field force of ~900 representatives, expanding distribution to 25 C&Fs and 4,000-5,000 distributors, executing strategic M&As (such as Minipress XL and ophthalmology in-licensing), and focusing on six core therapy areas.

Evidence summary ready
INDOBORAX
Indo Borax & Chemicals Limited
Industrials · Small
Sep 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
Guidance maintained

Indo Borax reported strong Q1 FY27 results with 31% operating revenue growth and a 59% jump in net profit, supported by robust execution and improved realizations. Management remains focused on operational efficiency, capacity utilization, and executing the acquisition of a majority stake in Kronox Lab Sciences.

Evidence summary ready
INDIGOPNTS
Indigo Paints Limited
Consumer · Micro
Sep 2026
19 Oct 2026
Transcript verified
Result pending
No matching current-quarter result row
Optimistic outlook
No comparable prior call
No measurable guidance

Indigo Paints delivered a strong Q1 FY27 with 18.7% standalone revenue growth and a 42% jump in EBITDA, outperforming the broader paint sector despite initial raw material supply disruptions triggered by the Iran conflict.

Evidence summary ready
Method: Deterministic quarterly-result score from reported growth, margin direction and operating leverage. Derived only from extracted, source-linked management evidence. Pending is shown when evidence is insufficient. Measurable claims are separated from general commentary and retain outcome status when later evidence exists. Transcript-verified summaries rank above preliminary presentation briefs and source-only call evidence. Preliminary briefs are replaced automatically when an official transcript is processed. Management outlook and colours describe extracted commentary evidence; they are not buy or sell labels.